sulthiame has been researched along with Adverse Drug Event in 2 studies
sulthiame: was heading 1964-94 (see under THIAZINES 1964-90); use THIAZINES to search SULTHIAME 1966-94
| Excerpt | Relevance | Reference |
|---|---|---|
| "The multiple drug interactions in which CAIs are involved should be carefully considered when such drugs are used in combination with the drug classes mentioned above, as the risks of developing toxicity and serious side effects if the dosages are not adjusted are high." | 2.53 | Drug interaction considerations in the therapeutic use of carbonic anhydrase inhibitors. ( Supuran, CT, 2016) |
| "Sulthiame was added in doses ranging from 10 to 30 mg/kg/day." | 1.72 | Use of sulthiame as add-on therapy in children with myoclonic atonic epilepsy: A study of 35 patients. ( Bautista, C; Cachia, P; Caraballo, RH; Espeche, A; Fortini, S; Galicchio, S; Gallo, A; Gamboni, B; Reyes Valenzuela, G; Semprino, M, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caraballo, RH | 1 |
| Reyes Valenzuela, G | 1 |
| Fortini, S | 1 |
| Espeche, A | 1 |
| Gamboni, B | 1 |
| Bautista, C | 1 |
| Cachia, P | 1 |
| Semprino, M | 1 |
| Gallo, A | 1 |
| Galicchio, S | 1 |
| Supuran, CT | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| An Open-label, Multi-center, Phase 1b Study to Investigate the Safety and Tolerability of SLC-0111 (WBI-5111) in Combination With Gemcitabine in Metastatic Pancreatic Ductal Adenocarcinoma Subjects Positive for Carbonic Anhydrase IX[NCT03450018] | Phase 1/Phase 2 | 30 participants (Anticipated) | Interventional | 2019-01-10 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for sulthiame and Adverse Drug Event
| Article | Year |
|---|---|
Drug interaction considerations in the therapeutic use of carbonic anhydrase inhibitors.
Topics: Acetazolamide; Anti-Inflammatory Agents, Non-Steroidal; Anti-Obesity Agents; Antibodies, Monoclonal; | 2016 |
1 other study available for sulthiame and Adverse Drug Event
| Article | Year |
|---|---|
Use of sulthiame as add-on therapy in children with myoclonic atonic epilepsy: A study of 35 patients.
Topics: Anticonvulsants; Child; Drug-Related Side Effects and Adverse Reactions; Epilepsy, Generalized; Huma | 2022 |